Immediate Impact
52 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Oxidase mimicking nanozyme: Classification, catalytic mechanisms and sensing applications
2024 Standout
Works of Federica Biello being referenced
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
2019
P2.01-067 The Relevance of CEA and CYFRA21-1 as Predictive Factors in Nivolumab Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Federica Biello | 608 | 408 | 258 | 286 | 56 | 955 | |
| Alexandros Xyrafas | 748 | 308 | 181 | 263 | 38 | 1.0k | |
| Marta Bonotto | 675 | 426 | 225 | 358 | 52 | 988 | |
| Danilo Rocco | 516 | 534 | 301 | 376 | 50 | 948 | |
| Shigehiro Yagishita | 532 | 284 | 339 | 235 | 63 | 974 | |
| Roberta Maltoni | 690 | 287 | 328 | 358 | 82 | 1.2k | |
| Zhenxiang Li | 469 | 271 | 311 | 222 | 65 | 906 | |
| Filippo Gustavo Dall’Olio | 576 | 403 | 169 | 208 | 38 | 895 | |
| Davide Lombardi | 593 | 301 | 200 | 206 | 57 | 968 | |
| E. Levchenko | 491 | 430 | 326 | 166 | 74 | 855 | |
| Naixin Liang | 505 | 415 | 239 | 207 | 34 | 857 |
All Works
Login with ORCID to disown or claim papers
Loading papers...